Experimental animal evidence (reviewed by Beltowski [5]) links elevations in circulating levels of the 16 kDa protein leptin via loss of leptin function or leptin resistance to atherogenesis and CAD but findings in human patients are less convincing [32]. Here, LEP is linked to coronary artery disorder.